logo
Cupid's Undie Run spreads the half-naked truth about Neurofibromatosis.

Cupid's Undie Run spreads the half-naked truth about Neurofibromatosis.

Yahoo09-02-2025
No, your eyes aren't playing tricks on you. There really were a few dozen scantily-clad runners making their way down Division Street on Saturday afternoon.
The group was baring almost all for a good cause: Nashville's annual Cupid's Undie Run. The charity run supports people affected by Neurofibromatosis, also known as NF, which is a group of incurable genetic conditions that cause tumors to grow on nerves throughout the body.
Nashville is one of 30 cities across the U.S. that host an Undie Run each year. Collectively, those events have raised $24 million toward finding a cure for NF since the charitable organization was founded about 15 years ago. This year, Nashvillians raised more than $17,000 for the Children's Tumor Foundation, a nonprofit that drives NF research.
In Nashville, event director Jason Corbitt has volunteered to organize the run for the past four years or so. Corbitt got involved because of his nephew, who was diagnosed with NF. Corbitt said the purpose of the run is to draw attention to a disease that many aren't aware of, affecting one in about 2,500 births across the country.
NF manifests in ways such as "café-au-lait" skin spots, pigmented birthmarks that differ in color from surrounding skin, and tumors that can grow anywhere in the nervous system — including the brain and spinal cord.
Corbitt said it's a condition that can make it hard to feel comfortable in your own skin, which is why Undie Run participants don't mind letting the common nightmare scenario of showing up to an event in only your underwear play out in real life.
"To have someone who feels that way and being able to help them feel better about themselves, or even try to give them a glimmer of hope of finding a cure, it's something that has attracted me to do this for the past eight years, almost 10 years now," Corbitt said.
Nancy Reeves, 49, has lived with NF for her whole life. She was diagnosed in 1980 at age 4 and is the only member of her family with the disorder. At one point, doctors told Reeves' parents she wouldn't make it to 21.
Instead, she's far surpassed that prognosis and made a successful life for herself. She and her husband, Mike, have been married for about a year, and they combined to raise the most in donations as a team and the second- and third-most as individuals for this year's run.
Reeves said she has what some may consider a more "mild case" of NF, the most common of three main types called NF1. Like others with the disease, she has tumors, and her symptoms included learning disabilities that went undiagnosed until college.
But the other, less common, types of the disease — NF2 and "Schwannomatosis" — can come with much more severe symptoms, like tumors that aren't just painful or itchy but also tend to more frequently affect the nerves inside the skull and spine and can disrupt hearing, balance and control of facial muscles as a result.
"I think one hurdle is that it doesn't affect (two people) the same way," Reeves told The Tennessean. "Every case is different, so I don't think they can pinpoint 'This is what's going to fix everybody.'"
That makes raising awareness through events like the Undie Run all the more important. Reeves started out as a participant, then became a volunteer four years ago. Now, she coordinates decorations at the venue where participants hang out before and after the run.
Reeves has seen the event grow year over year in the decade since it began in Nashville, and she said along with that has come a larger group of participants who are learning about NF for the first time.
"I've met people today that are like, 'Oh, my god, thank you for telling me your story,'" Reeves said.
It's a far cry from where research stood on the disease back in the 1980s, when Reeves was diagnosed.
"Back when I was growing up, not much was known about (NF)," Reeves said. "Now there's so much research and drug studies and stuff like that that are helping people with that. So I think events like this are helping find a cure — hopefully in my lifetime, there will be, because I don't want any other children to have to go through what I went through growing up."
To learn more about Nashville's chapter of the Undie Run event, visit the Cupid's Undie Run website, cupids.org. More information about the Children's Tumor Foundation — including how to donate — is available on the nonprofit's website, ctf.org.
This article originally appeared on Nashville Tennessean: Runners get half-naked in Cupid's Undie Run to raise money for condition
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies
BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies

Yahoo

time05-07-2025

  • Yahoo

BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies

BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the best new stocks to buy now. On June 18, BrightSpring Health Services announced that its specialty pharmacy, called Onco360, has been chosen as the national pharmacy partner for several newly approved therapies. These innovative treatments target advanced cancers and rare genetic disorders. BrightSpring delivers care and clinical solutions to 400,000+ customers, clients, and patients daily across all 50 states. Onco360 will provide access, education, data, and expert support for patients suffering from advanced ovarian and lung cancers, as well as neurofibromatosis type 1. A medical technician using surgical robotics to perform minimally-invasive urologic surgery in an operating room. Onco360 has been selected as a pharmacy partner for the following specific medication therapies: GOMEKLI, which is approved for adult and pediatric patients aged 2 years and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas/PN not suitable for complete resection; AVMAPKI FAKZYNJA CO-PACK, which is approved for adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer/LGSOC who have received prior systemic therapy; and IBTROZI, which is approved for adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC). BrightSpring Health Services Inc. (NASDAQ:BTSG) is a home and community-based healthcare services platform in the US that operates through 2 segments: Pharmacy Solutions and Provider Services. Onco360 is a national, independent Oncology Pharmacy and clinical support services company. While we acknowledge the potential of BTSG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Michigan Matters: Gearing up for a healthier and high-flying future
Michigan Matters: Gearing up for a healthier and high-flying future

CBS News

time04-07-2025

  • CBS News

Michigan Matters: Gearing up for a healthier and high-flying future

Dr. Ivan Baines of the Nick Gilbert Neurofibromatosis Research Institute and Dr. Steven Kalkanis of Henry Ford Health appear on Michigan Matters this Sunday to discuss the impact of a new research center coming to life in the heart of Detroit and the timeline of its opening. Dr. Ivan Baines and Dr. Steven Kalkanis Tim Lawlis/CBS Detroit The two leaders discussed how it will not only help in the fight against neurofibromatosis — a genetic disease — but also others, like cancer. The institute was made possible by entrepreneur Dan Gilbert and his wife, Jennifer, who lost their son, Nick, to the disease. The couple has donated millions to it and much more at the new medical hub. Henry Ford Health, Michigan State University, and others are also involved. Then Tony Vernaci of the Aerospace Industry Association of Michigan, Jeff Simek of RCO Aerospace and Engineering, and Kevin Michaels of AeroDynamic Advisory appear on the roundtable as they discuss efforts to grow the aerospace industry. Tony Vernaci, Jeff Simek and Kevin Michaels Tim Lawlis/CBS Detroit Michigan has been involved since World War II, when Ford's Willow Run Assembly Plant was transformed to build bombers used to help win the war. The trio talked about opportunities today, before the region and down the road. (Watch Michigan Matters at its new time: 5:30 a.m. Sundays on CBS Detroit and 9:30 a.m. Sundays on CW Detroit 50 WKBD). (Carol Cain is the 13-time Emmy-winning senior producer and host of Michigan).

Anaplastic Astrocytoma
Anaplastic Astrocytoma

Health Line

time25-06-2025

  • Health Line

Anaplastic Astrocytoma

This rare, aggressive type of cancerous brain tumor can cause headaches, seizures, and changes in behavior or cognitive (thinking) function. Treatment involves surgery combined with radiation and chemotherapy. Astrocytomas are a type of brain tumor. They develop in star-shaped brain cells called astrocytes, which form part of the tissue that protects the nerve cells in your brain and spinal cord. Astrocytomas are classified by their grade — grade 1 and 2 astrocytomas grow slowly, while grade 3 and 4 astrocytomas grow faster and more aggressively. An anaplastic astrocytoma is a grade 3 astrocytoma. While rare, this type of cancerous tumor can be very serious without treatment. Keep reading to learn more about anaplastic astrocytomas, including their symptoms and the survival rates of people who have them. What are the symptoms? The symptoms of an anaplastic astrocytoma can vary based on exactly where the tumor is, but generally include: headaches lethargy or drowsiness nausea or vomiting behavioral changes memory loss seizures vision problems coordination and balance problems What causes it? Researchers aren't sure what causes anaplastic astrocytomas. However, they may be associated with: genetic abnormalities immune system abnormalities environmental factors, such as exposure to UV rays and certain chemicals lifestyle factors, such as diet or stress People with certain genetic disorders, such as neurofibromatosis type I (NF1), Li-Fraumeni syndrome, or tuberous sclerosis, have a higher risk of developing anaplastic astrocytoma. If you've had radiation therapy on your brain, you may also be at a higher risk. How is it diagnosed? Anaplastic astrocytomas are rare, so your doctor will start by discussing your medical history and performing a physical exam to identify any other possible causes of your symptoms. They may also use a neurological exam to see how your nervous system is working. This usually involves testing your balance, coordination, and reflexes. You may be asked to answer some basic questions so they can evaluate your speech and mental clarity. If your doctor thinks you may have a tumor, they'll likely use imaging such as an MRI scan or CT scan to examine a picture of your brain. If you do have an anaplastic astrocytoma, these images will also show its size and exact location. In some cases, doctors use a PET scan or SPECT scan. These metabolic scans look at cellular activity in the brain rather than the detailed anatomy seen on an MRI. These tests can sometimes be helpful for assessing tumor cells. A biopsy may also be part of the diagnostic process and can involve removing as much of the tumor as possible. How is it treated? There are several options for treating an anaplastic astrocytoma, depending on the size, location, and grade of the tumor. Surgery Surgery is usually the first step in treating an anaplastic astrocytoma. In some cases, your doctor may be able to remove all or as much of the tumor as possible. However, anaplastic astrocytomas may grow in areas of the brain that are not safe or accessible for surgery, so your doctor may only be able to safely remove part of the tumor. Tumor cells that remain because they were not identified or were surgically inaccessible can grow quickly after surgery. Chemotherapy and radiation therapy If your tumor can't be removed with surgery or was only partially removed, you may need follow-up treatment. Radiation therapy destroys cells, especially rapidly dividing cancer cells. This will help shrink the tumor or destroy some or all of the cells that weren't removed during surgery. Anticancer drugs are referred to as chemotherapy and may be used with or after radiation therapy to continue treatment. Some people may also be treated with: epilepsy medication hydrocephalus treatment steroids physical therapy Survival rate and life expectancy According to the American Cancer Society, the 5-year relative survival rate for people with an anaplastic astrocytoma is as follows: 58% for those ages 22 to 44 29% for those ages 45 to 54 15% for those ages 55 to 64 The relative survival rate suggests how long someone with a condition may live after their diagnosis compared to those without the condition of the same race, sex, and age over a specific time. This is different from the overall survival rate, which is a percentage of people still alive for a specific time after diagnosis of a condition. It's most important to remember that these figures are estimates, and everyone is different. You can talk with your doctor about your specific condition. Several factors can affect your survival rate, including: the size, location, and grade of your tumor whether the tumor was completely or partially removed with surgery whether the tumor is new or recurring your overall health Your doctor can give you a better idea of your outlook based on these factors. The takeaway Anaplastic astrocytoma is a rare, aggressive type of cancerous brain tumor. Symptoms can vary but often include headache, seizures, and changes in behavior or cognitive function.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store